Why Hunuu Wins
We're not competing with wearables or EMRs. We're the intelligence layer above them all.
Hunuu vs. Everyone Else
| Feature | Hunuu Health | Apple/Oura/Whoop | Epic / Cerner | Function Health |
|---|---|---|---|---|
| 50+ device integrations | ✓ | Own device only | ✗ | ✗ |
| 30-day predictive forecasting | ✓ | ✗ | ✗ | ✗ |
| SIQ provider scoring | ✓ | ✗ | ✗ | ✗ |
| EHR interoperability | ✓ | ✗ | ✓ | Partial |
| Patient-owned data | ✓ | ✗ | ✗ | ✗ |
| Health Circle QR sharing | ✓ | ✗ | ✗ | ✗ |
| Lifetime access pricing | $25 once | $99–299/yr | $50M+ enterprise | $499/yr |
9 Live APIs. Zero Competitors Have This Stack.
While competitors build one-device silos, Hunuu runs a full API ecosystem: NPI Registry, FDA Drug Database, PubMed (35M+ citations), CourtListener (malpractice), RxNorm, Claude AI, Apple/Oura/Whoop device APIs, Stripe, and the SIQ Score API. This stack took years to build. It's not something anyone replicates in a funding cycle.
One Scoring Engine. An Entire Ecosystem.
Most health companies sell one product to one user. Hunuu built a scoring methodology — the Signal Intelligence Quotient — that powers a four-product platform where every user, every provider, and every data stream makes the whole system smarter. This is why competitors can’t catch us: they’re selling features. We’re running a flywheel.
50+ wearables unified. LSTM models at 94.2% predictive accuracy, 30-day forecast horizon. The consumer front door — where biometric signals enter the ecosystem.
The CarFax for healthcare providers. Four dimensions — Trust · Wellness · Accessibility · Transparency — scored from outcomes, not reviews. Patent-pending methodology.
The first dating platform where members verify real biometric health, not filtered selfies. Built on HIP credentials. Monetizes premium users at 20–50× consumer ARPU.
Every score, every signal, every provider rating — exposed as an API. Payers, employers, hospitals, and dev teams license the underlying intelligence.
How Each Product Feeds the Next
User biometrics enter the system. HRV, sleep, glucose, cortisol, testosterone, blood pressure, VO2 Max — 50+ streams per user, continuously. Every user makes our LSTM models smarter for every other user.
Outcomes become scores. When a HIP user sees a provider, we track whether the biomarkers actually improve. Providers who consistently move the needle earn higher SIQ Trust and Wellness scores — and that score becomes a market signal.
Verified health becomes social capital. Members use their HIP credentials to prove what they actually look like inside — HRV, metabolic age, recovery score. Premium subscriptions fund the consumer tier and enrich the scoring dataset.
Payers, employers, and hospitals pay to access the intelligence. Their usage generates revenue that funds better models, which make HIP more predictive, which makes SIQ more trusted, which makes Velato more desirable, which generates more data. The loop closes.
Why Competitors Can’t Reach Us
Every new HIP user sharpens the LSTM models for every existing user. Every provider visit refines SIQ. By month 12, our predictive accuracy compounds beyond what a new entrant can match even with unlimited capital.
Two issued US patents covering the core scoring methodology and multi-stream biometric fusion. A third is pending. Anyone replicating SIQ Score hits a wall at the IP layer — not 18 months away, today.
A user on HIP, SIQ, and Velato has three reasons to stay and zero alternatives that span all three. Competitors offer one of these. We offer the whole stack — and the data fluidity between them is the product.
HIPAA-compliant architecture, SOC 2 in progress, Gold Star Family governance. Healthcare buyers require this before they even take a meeting. Building it retroactively costs a competitor 12–24 months we spent getting right the first time.
Competitors sell features. We run a scoring engine that compounds value across four products — each one making the next one worth more. That’s not a product moat. That’s an ecosystem moat. And it’s already running.